🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares the immune response to the proposed biosimilar PF-06881...
Status
Completed
Location
Seaview A Quotient Clinical Business
Start Date
2017-10-27
Trial ID
NCT03273842
Treatments Being Tested
The study was an assessor-blind, balanced, randomized, two-treatment, two-p...
Status
Completed
Location
Lambda Therapeutic Research Ltd.
Start Date
2018-02-12
Trial ID
NCT04014062
Treatments Being Tested
The study was an assessor-blind, balanced, parallel, randomized, two-treatm...
Status
Unknown
Location
Parexel International GmbH Early Phase Clinical Unit Berlin
Start Date
2020-11-06
Trial ID
NCT04651036
Treatments Being Tested
This is a single center, double-blind, randomized, comparative pharmacokine...
Status
Completed
Location
PRA Health Sciences - Early Development Services
Start Date
2014-09
Trial ID
NCT02479646
Treatments Being Tested
The long-term outcome of patients with acute myeloid leukemia (AML) remains...
Status
Completed
Location
University Hospital Heidelberg, Internal Medicine V
Start Date
2019-10-22
Trial ID
NCT04173585
Treatments Being Tested
A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossov...
Status
Recruiting
Location
Ethics Committee of Hopeshine-Minsheng Hospital of Xinzheng, Zhengzhou,
Start Date
2026-07-03
Trial ID
NCT07738991
Treatments Being Tested
The primary purpose of this study is to compare the immunogenicity and safe...
Status
Completed
Location
Auckland Clinical Studies Ltd
Start Date
2017-08-21
Trial ID
NCT03251339
Treatments Being Tested
The study was an assessor-blind, balanced, parallel, randomized, two-treatm...
Status
Completed
Location
Lambda Therapeutic Research Ltd.
Start Date
2018-02-26
Trial ID
NCT04015232
Treatments Being Tested
This study is for healthy participants. This study tests single dose of the...
Status
Completed
Location
CMAX (a Division of IDT Australia Limited)
Start Date
2015-08
Trial ID
NCT02629289
Treatments Being Tested